Fennec Pharmaceuticals (FENC) EPS (Basic) (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly EPS (Basic) came in at -$0.16 in Q4 2025, down 259.33% YoY from $0.1 in Q4 2024, and down 638.44% on a QoQ basis from -$0.02 in Q3 2025.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) EPS (Basic) (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of EPS (Basic) data on file, last reported at -$0.16 in Q4 2025.
- Quarterly EPS (Basic) fell 259.33% year-over-year to -$0.16 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.34 (down 2249.76% YoY) and the FY2025 annual result came in at $0.22, down 49.29% from the prior year.
- EPS (Basic) eased to -$0.16 in Q4 2025, from -$0.02 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.48 in Q1 2024 to a low of -$163.65 in Q4 2021.
- A 5-year average of -$8.3 and a median of -$0.16 in 2021 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2021 — EPS (Basic) slumped 11150.78% — and 2024, when it jumped 312.69%.
- Tracing FENC's EPS (Basic) over 5 years: stood at -$163.65 in 2021, then surged by 99.84% to -$0.26 in 2022, then soared by 61.51% to -$0.1 in 2023, then soared by 53.4% to -$0.05 in 2024, then slumped by 259.33% to -$0.16 in 2025.
- The last three EPS (Basic) figures came in at -$0.16 (Q4 2025), -$0.02 (Q3 2025), and -$0.11 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn | 0.06 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.06 |
| Dec 31, 2025 | -0.09 |
| Sep 30, 2025 | -0.02 |
| Jun 30, 2025 | -0.11 |
| Mar 31, 2025 | -0.04 |
| Dec 31, 2024 | -0.05 |
| Sep 30, 2024 | -0.21 |
| Jun 30, 2024 | -0.20 |
| Mar 31, 2024 | 0.48 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -0.07 |
| Jun 30, 2023 | -0.20 |
| Mar 31, 2023 | -0.22 |
| Dec 31, 2022 | -0.26 |
| Sep 30, 2022 | -0.31 |
| Jun 30, 2022 | -0.19 |
| Mar 31, 2022 | -0.14 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | -0.16 |
| Jun 30, 2021 | -0.15 |